Minot Wealth Management’s X4 Pharmaceuticals XFOR Stock Holding History

Minot Wealth Management’s Portfolio XFOR Stock Details XFOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$53K	Hold	1,833	–	–	0.01%	178
2022 Q1	$96K	Buy	+1,833	New	+$105K	0.02%	195
2021 Q4	–	Sell	-567	Closed	-$90K	–	217
2021 Q3	$90K	Hold	567	–	–	0.02%	200
2021 Q2	$103K	Buy	+567	New	+$143K	0.02%	197
2021 Q1	–	Sell	-784	Closed	-$151K	–	211
2020 Q4	$151K	Buy	+784	New	+$154K	0.05%	151

Other funds holding XFOR

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

TLP

Tri Locum Partners New York $713M AUM 68.92% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Minot Wealth Management's XFOR Position: Q2 2022 in Review

Minot Wealth Management held its X4 Pharmaceuticals (XFOR) position steady in Q2 2022 at 1,833 shares worth $53K. The position accounts for 0.01% of the portfolio, ranked #178.

Minot Wealth Management first reported a position in XFOR in Q4 2020 and has held it in 5 quarters since. The position peaked at $151K in Q4 2020. 49 funds tracked by Wall St. Rank hold XFOR as of Q2 2022.

Minot Wealth Management held 1,833 shares of X4 Pharmaceuticals worth $53K as of Q2 2022.
Minot Wealth Management left its X4 Pharmaceuticals share count unchanged in Q2 2022.
X4 Pharmaceuticals made up 0.01% of Minot Wealth Management's portfolio in Q2 2022, its #178 holding.
Minot Wealth Management first reported a position in X4 Pharmaceuticals in Q4 2020 and has held it in 5 quarters since.
Minot Wealth Management's X4 Pharmaceuticals position peaked at $151K in Q4 2020.
49 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2022.

Based on Minot Wealth Management's 13F filing for Q2 2022, filed 12 Jul 2022.